AURINIA PHARMACEUTICALS INC. v. SUN PHARMACEUTICAL INDUSTRIES, INC.
3:20-cv-19805
Overview
Parties
Defendant
SUN PHARMA GLOBAL FZE Operating Company
Represented By
2 Attorneys ListedRIVKIN RADLER LLP
25 MAIN STREET, SUITE 501, COURT PLAZA NORTH
SUN PHARMACEUTICAL INDUSTRIES, LTD. Operating Company
Represented By
2 Attorneys ListedRIVKIN RADLER LLP
25 MAIN STREET, SUITE 501, COURT PLAZA NORTH
SUN PHARMACEUTICAL INDUSTRIES, INC. Operating Company
Represented By
2 Attorneys ListedRIVKIN RADLER LLP
25 MAIN STREET, SUITE 501, COURT PLAZA NORTH
Plaintiff
AURINIA PHARMACEUTICALS INC. Operating Company
Represented By
2 Attorneys ListedICE MILLER LLP
1735 MARKET STREET, SUITE 3900
BAKER & HOSTETLER LLP
45 ROCKEFELLER PLAZA, NEW YORK, NY 10111
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10265375
Ophthalmic compositions
|
Filed: 2015-02-20
Issued: 2019-04-23
|
Active (8.3 yrs remaining)
Expires: 2035-02-20
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
42
Dispositive
0
Granted
14
Denied
2
Pending / Review
17
Motions by Category
Key Dispositive Motions & Rulings